| 1 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [J]. CA Cancer, 2016, 66(1):7-30.
|
| 2 |
Chen W, Zheng R, Baade PD, et a1. Cancer statistics in China, 2015 [J]. CA Cancer, 2016, 66(2):115-132.
|
| 3 |
Petrakis IE, Paraskakis S. Breast cancer in the elderly [J]. Arch gerontol geriatr, 2010, 50(2):179-184.
|
| 4 |
Jia Y, Chen Y, Wang Q, et al. Exosome: emerging biomarker in breast cancer [J]. Oncotarget, 2017, 8(25):41717-41733.
|
| 5 |
Lobb RJ, van Amerongen R, Wiegmans A, et al. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance [J]. Int J Cancer, 2017, 141(3):614-620.
|
| 6 |
Franzen CA, Blackwell RH, Foreman KE, et al. Urinary exosomes: the potential for biomarker utility, intercellular signaling, and therapeutics in urologic malignancy [J]. J Urol, 2016, 195(5):1331-1339.
|
| 7 |
Tang XJ, Sun XY, Huang KM, et al. Therapeutic potential of CAR—T cell-derived exosomes: a cell-free modality for targeted cancer therapy [J]. Oncotarget, 2015, 6(42):44179-44190.
|
| 8 |
Nikitina IG, Sabirova EIu, Karpov VL, et al. The role of exosomes and microvesicles in carcinogenesis [J]. Mol Biol(Mosk). 2013, 47(5):767-773.
|
| 9 |
Sun Y, Liu J. Potential of cancer cell-derived exosomes in clinical application：a review of recent research advances [J]. Clin Ther, 2014, 36(6):863-872.
|
| 10 |
O′Brien K, Rani S, Corcoran C, et al. Exosomes from triple—negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells [J]. Eur J Cancer, 2013, 49(8):1845-1859．
|
| 11 |
Keller S, König AK, Marmé F, et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes [J]. Cancer Lett, 2009, 278(1):73-81.
|
| 12 |
Rodríguez M, Silva J, Herrera A, et al. Exosomesenriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer [J]. Oncotarget, 2015, 6(38):40575-40587.
|
| 13 |
Kannan A, Wells RB, Sivakumar S, et al. Mitochondrial reprogramming regulates breast cancer progression [J]. Clin Cancer Res, 2016, 22(13):3348-3360.
|
| 14 |
Harris DA, Patel SH, Gucek M, et al. Exosomes released from breast cancer carcinomas stimulate cell movement [J]. PLoS One, 2015, 10(3):e0117495.
|
| 15 |
Zhou W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis [J]. Cancer Cell, 2014, 25(4):501-515.
|
| 16 |
Yang M, Chen J, Su F, et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells [J]. Mol Cancer, 2011, 10:117.
|
| 17 |
Singh R, Pochampally R, Watabe K, et al. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer [J]. Mol Cancer, 2014, 13:256.
|
| 18 |
Shi J, Ren Y, Zhen L, et al. Exosomes from breast cancer cells stimulate proliferation and inhibit apoptosis of CD133+ cancer cells in vitro [J]. Mol Med Rep, 2015, 11(1):405-409.
|
| 19 |
Lin R, Wang S, Zhao RC. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model [J]. Mol Cell Biochem, 2013, 383(1-2):13-20.
|
| 20 |
Gorczynski RM, Erin N, Zhu F. Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor [J]. Cancer Med, 2016, 5(2):325-336.
|
| 21 |
Chen WX, Liu XM, Lv MM, et al. Exosomes from drugresistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs [J]. PLoS One, 2014, 9(4):e95240.
|
| 22 |
Chen WX, Cai YQ, Lv MM, et al. Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs [J]. Tumour Biol, 2014, 35(10):9649-9659.
|
| 23 |
Yu DD, Wu Y, Zhang XH, et al. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222 [J]. Tumour Biol, 2016, 37(3):3227-3235.
|
| 24 |
Lv MM, Zhu XY, Chen WX, et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein [J]. Tumour Biol, 2014, 35(11):10773-10779.
|
| 25 |
Ciravolo V, Huber V, Ghedini GC, et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy [J]. J Cell Physiol, 2012, 227(2):658667.
|
| 26 |
Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers [J]. Nat Cell Biol, 2008, 10(12):1470-1476.
|
| 27 |
Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET [J]. Nat Med, 2012, 18(6):883-891.
|
| 28 |
Lan CS, Wong DT. Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell--derived exosome-like mierovesieles in vitro [J]. PLoS One, 2012, 7(3):e33037.
|
| 29 |
Khan S, Bennit HF, Turay D, et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer [J]. BMC Cancer, 2014, 14:176.
|
| 30 |
Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer [J]. Nature, 2015, 523(7559):177-182.
|
| 31 |
Roberg-Larsen H, Lund K, Seterdal KE, et al. Mass spectrometric detection of 27-hydroxycholesterol in breast cancer exosomes [J]. J Steroid Biochem Mol Biol, 2017, 169:22-28.
|
| 32 |
盛湲，李恒宇. 外泌体:乳腺癌精确诊疗的新热点 [J/CD]. 中华乳腺病杂志(电子版), 2016, 10(3):133-136.
|
| 33 |
Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy [J]. Biomaterials, 2014, 35(7):2383-2390.
|
| 34 |
Ohno S, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells [J]. Mol Ther, 2013, 21(1):185-191.
|
| 35 |
Hadla M, Palazzolo S, Corona G, et al. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models [J]. Nanomedicine(Lond), 2016, 11(18):2431-2441.
|
| 36 |
Marleau AM, Chen CS, Joyce JA, et al. Exosome removal as a therapeutic adjuvant in cancer [J]. J Transl Med, 2012, 10:134.
|
| 37 |
Tan A, De La Peña H, Seifalian AM. The application of exosomes as a nanoscale cancer vaccine [J]. Int J Nanomedicine, 2010, 5:889-900.
|